Product Recalls in New Hampshire

Product recalls affecting New Hampshire — including food, drugs, consumer products, medical devices, and vehicles distributed to New Hampshire. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,579 recalls have been distributed to New Hampshire in the last 12 months.

49,311 total recalls
2,579 in last 12 months

Showing 801820 of 13,374 recalls

DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablet Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 15, 2024· Evaric Pharmaceuticals Inc.

Recalled Item: Lisinopril Tablets Recalled by Evaric Pharmaceuticals Inc. Due to Foreign...

The Issue: Presence of Foreign Object: A pharmacist discovered a metal fragment...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 14, 2024· Keystone Industries

Recalled Item: Gelato Recalled by Keystone Industries Due to CGMP deviations: the bulk...

The Issue: CGMP deviations: the bulk product was rejected by the Quality Unit after...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 14, 2024· Keystone Industries

Recalled Item: Henry Schein Recalled by Keystone Industries Due to CGMP deviations: the...

The Issue: CGMP deviations: the bulk product was rejected by the Quality Unit after...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 14, 2024· Keystone Industries

Recalled Item: Quala Dental Products Recalled by Keystone Industries Due to CGMP...

The Issue: CGMP deviations: the bulk product was rejected by the Quality Unit after...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 14, 2024· Keystone Industries

Recalled Item: safco Recalled by Keystone Industries Due to CGMP deviations: the bulk...

The Issue: CGMP deviations: the bulk product was rejected by the Quality Unit after...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund